The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 25, 2020

Filed:

Apr. 17, 2015
Applicant:

Korea Research Institute of Bioscience and Biotechnology, Daejeon, KR;

Inventors:

Sei Ryang Oh, Daejeon, KR;

Kyung Seop Ahn, Daejeon, KR;

Seung Hyung Kim, Daejeon, KR;

In Sik Shin, Daejeon, KR;

Hang Jin, Yunnan, CN;

Jung Hee Kim, Daejeon, KR;

Hyung Won Ryu, Daejeon, KR;

Wan Yi Li, Yunnan, CN;

Sang Woo Lee, Daejeon, KR;

Joong Ku Lee, Daejeon, KR;

Sang Ho Choi, Daejeon, KR;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 36/22 (2006.01); A23L 33/105 (2016.01); A61K 9/00 (2006.01); A61K 31/12 (2006.01); A61P 11/00 (2006.01);
U.S. Cl.
CPC ...
A61K 36/22 (2013.01); A23L 33/105 (2016.08); A61K 9/0053 (2013.01); A61K 31/12 (2013.01); A23V 2002/00 (2013.01); A61K 2236/33 (2013.01); A61P 11/00 (2018.01);
Abstract

The present invention relates to a composition for suppressing chronic obstructive pulmonary disease (COPD) comprising aextract, a fraction thereof, or a compound isolated therefrom and, more particularly, to a pharmaceutical composition for preventing or treating COPD comprising aextract, a fraction thereof, or a compound isolated therefrom; a food composition for preventing or improving COPD, and the compound isolated therefrom. The composition comprising aextract, a fraction thereof, or a compound isolated therefrom, according to the present invention, is not toxic, suppresses the invasion of inflammatory cells into the bronchial tube of a COPD-induced animal model, and effectively suppresses the expression of CXCL-1, TNF-α, or MIP-2. In addition, due to the use of a safety-proven herbal drug as a raw material, the composition of the present invention can resolve various side-effects of existing therapeutic agents for COPD, chronic obstructive bronchitis, chronic bronchiolitis, emphysema, multiple sclerosis, and acute and chronic inflammation, and thus can be effectively used as a composition for preventing, treating and remedying COPD.


Find Patent Forward Citations

Loading…